Paper Review Records
全部论文审稿周期
5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
174
天
ECM1 produced by hepatic stellate cells serves as a gatekeeper of liver homeostasis in hepatic fibrosis
作者
Aiting Yang; Xuzhen Yan; Yiwen Wang; Qi Han; Xiaofei Tong; Shuyan Chen; Xinyu Zhao; Wei Chen; Jidong Jia; Detlef Schuppan; Hong You展开收起
作者单位
1. Experimental and Translational Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, P.R. China; 2. Beijing Clinical Medicine Institute, Beijing, P.R. China; 3. State Key Lab of Digestive Health, Beijing, P.R. China; 4. National Clinical Research Center of Digestive Diseases, Beijing, P.R. China; 5. Institute of Translational Immunology and Research Center for Immune Therapy, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany; 6. Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, P.R. China; 7. Department of Hepatobiliary Surgery and Liver Transplant Center, The First Hospital of Shanxi Medical University, Taiyuan, P.R. China; 8. Clinical Epidemiology and Evidence-Based Medicine Unit, Beijing Friendship Hospital, Capital Medical University, Beijing, P.R. China; 9. Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA展开收起
95
天
Reduced risk of liver-related events among patients receiving individualized nutrition-focused remote care in the United States
作者
Shaminie J. Athinarayanan; Adam J. Wolfberg; Priya V. Shanmugam; Bilal A. Hameed; Maurizio Bonacini展开收起
作者单位
1. Departments of Research, Virta Health, Denver, Colorado, USA; 2. Transplant Hepatology, School of Medicine, University of California, San Francisco, California, USA; 3. Mission Gastroenterology and Hepatology, University of California, San Francisco, California, USA展开收起
119
天
Hepatic GPR75 exacerbates MASH through GNAI2-dependent signaling
作者
Xule Yang; Na Yang; Zhihao Cheng; Rui Zhang; Hui Fan; Dongsheng Liu; Jiye Aa; Guangji Wang; Yuan Xie展开收起
作者单位
1. Key Laboratory of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China; 2. China Pharmaceutical University Nanjing Drum Tower Hospital, Nanjing, China; 3. Research Unit of PK-PD Based Bioactive Components and Pharmacodynamic Target Discovery of Natural Medicine of Chinese Academy of Medical Sciences, China Pharmaceutical University, Nanjing, China展开收起
98
天
Repurposing Resmetirom suppresses MASH-associated hepatocellular carcinoma, with mechanistic implications of MDK/LRP1-mediated metabolic reprogramming and immunosuppression
作者
Vanilla Xin Zhang; Tina Suoangbaji; Yu‑Man Tsui; Karen Man-Fong Sze; Eva Lee; Lu Tian; Jingyi Lu; Huan Deng; Abdullah Husain; Charry Shuk-Ching Hui; Joyce Man-Fong Lee; Daniel Wai-Hung Ho; Irene Oi-Lin Ng展开收起
作者单位
1. Department of Pathology, The University of Hong Kong, Hong Kong SAR, China; 2. State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong SAR, China; 3. Department of Pathology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China展开收起
174
天
Pruritus is common in primary sclerosing cholangitis, persists over time, and its intensity is associated with disease severity: a multicentre, prospective observational study
作者
Nasir Hussain; Rodrigo V. Motta; Usha Gungabissoon; Linda Casillas; Sumanta Mukherjee; Andrea Ribeiro; Megan M. Mclaughlin; Kaitlin Hagan; Khushpreet Bhandal; Penelope Rogers; Martine Walmsley; James Ferguson; Andreas E. Kremer; Emma L. Culver; Palak J. Trivedi展开收起
作者单位
1. National Institute of Health and Care Research (NIHR) Birmingham Biomedical Research Centre (BRC), University of Birmingham, Birmingham, UK; 2. Centre for Liver and Gastrointestinal Research, School of Infection, Inflammation. and Immunology, University of Birmingham, Birmingham, UK; 3. Liver Unit, University Hospitals Birmingham National Health Service Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK; 4. Translational Gastroenterology and Liver Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; 5. GSK, London, UK; 6. GSK, Collegeville, Pennsylvania, USA; 7. GSK, Madrid, Spain; 8. PSC Support, Oxford, UK; 9. Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; 10. National Institute of Health and Care Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, UK展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天